About BMP Sunstone
BMP Sunstone is a Healthcare company based in Chicago (United States) founded in 2003, and was acquired by Sanofi in October 2010. BMP Sunstone has raised $31.3 million across 6 funding rounds from investors including Sanofi. Its focus areas include Traditional Pharmaceuticals.
Company details
Manufacturer of composite stone facade and finishing elements. It produces a wide assortment of standard and custom-designed products for both new construction and renovation projects. These products include window sills, coping stones, wall caps, thresholds, and various other architectural components. The company also provides specialized solutions for the window and door industry, offering a variety of sill systems. A focus on bespoke solutions allows for tailored designs to meet specific project requirements.
- Headquarters Chicago, United States
- SectorsHealthcare
- Website bmpsunstone.com
- Social LinkedIn
- Acquired by Sanofi (Oct 2010)
Funding Insights of BMP Sunstone
BMP Sunstone has successfully raised a total of $31.3M across 6 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $6.35 million completed in March 2009. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $31.3M
- Total Rounds 6
- Last Round Debt – Conventional — $6.35M
- First Round $10M
(Apr 2004)
All 6 funding rounds of BMP Sunstone with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2009 | $6.35M | Debt – Conventional | – | – | – |
| Nov 2007 | $129,698 | Debt – Convertible | – | – | – |
| Oct 2007 | $23M | Debt – Convertible | – | – | – |
| Jan 2007 | $15M | Series B | – | – | – |
| Nov 2005 | $6.3M | Series A | – | – | – |
| Apr 2004 | $10M | Series A | – | – | – |
1 investors in total: 1 institutional.
Investors in BMP Sunstone
BMP Sunstone has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Sanofi.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Pharmaceutical and nutraceutical products are developed across seven therapeutic areas. | 1973 | sanofi.com | Paris, France |
Investor details for BMP Sunstone
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of BMP Sunstone
4 dated milestones of BMP Sunstone across 7 years, from founding to its latest funding, stage changes and deals.
- Founded BMP Sunstone is founded.
- Funding First funding round of $10.0M.
- Funding Latest funding round, Debt – Conventional, of $6.3M.
- Exit Acquired by Sanofi.
Top companies in Traditional Health & Nutrition
10 companies that operate in the same segment as BMP Sunstone (Traditional Health & Nutrition), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Manufacturer of generics formulations | 2002 | Bridgewater, New Jersey, United States | – | USD 3.02 B | 8,300 | |
Biosimilar therapeutics are developed for oncology and autoimmune diseases. | 2010 | Redwood City, California, United States | USD 143.62 M | USD 42.17 M | 228 | |
Oral solid drug delivery systems are manufactured and developed. | 1985 | Mumbai, Maharashtra, India | USD 42.49 M | USD 89.42 M | 962 | |
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | – | USD 5.1 B | 13,500 | |
Generic pharmaceuticals are manufactured by Teva Pharmaceuticals. | 1901 | Petah Tikva, Central District, Israel | USD 500 M | USD 18.74 B | 51,792 | |
Generic, semi-solid, and liquid dosage forms are manufactured. | 1990 | Bengaluru, Karnataka, India | – | USD 508.93 M | 5,180 | |
Pharmaceutical products are developed and marketed globally. | 2009 | Montville, New Jersey, United States | USD 155.92 M | – | – | |
Specialty generic pharmaceuticals and APIs are manufactured and marketed. | 1983 | Mumbai, Maharashtra, India | – | USD 6.21 B | 25,870 | |
Pharmaceutical company engaged in developing, manufacturing, and marketing a diverse range of pharmaceutical formulations | 1991 | Delhi, Delhi, India | USD 367.2 M | USD 1.52 B | 21,320 | |
Generics, biosimilars, APIs, and vaccines are manufactured by Wockhardt. | 1967 | Mumbai, Maharashtra, India | – | USD 353.53 M | 3,410 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about BMP Sunstone
BMP Sunstone was founded in 2003 and raised its 1st funding round 1 year after it was founded.
BMP Sunstone is headquartered in Chicago, United States. It is registered at Chicago, Illinois, United States.
BMP Sunstone is a funded company, having raised a total of $31.3M across 6 funding rounds to date. The company's 1st funding round was a Series A of $10M, raised on Apr 2004.
Manufacturer of composite stone facade and finishing elements. It produces a wide assortment of standard and custom-designed products for both new construction and renovation projects. These products include window sills, coping stones, wall caps, thresholds, and various other architectural components. The company also provides specialized solutions for the window and door industry, offering a variety of sill systems. A focus on bespoke solutions allows for tailored designs to meet specific project requirements.
BMP Sunstone has 1 investor. Key investors include Sanofi.
Yes. BMP Sunstone was acquired by Sanofi in October 2010.